Pyxis Oncology, Inc. (PYXS)

NASDAQ

$1.86

$+0.07

(+4.26%)

Regular Market

Pyxis Oncology, Inc. (PYXS) Live Price Chart

Last updated: ⁦2026-10-20 14:37:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Pyxis Oncology, Inc. (PYXS) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.86, with a market capitalization of $140.13M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.03 to $5.55. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$140.13M
Open	$1.76
Day's High	$19.00
Day's Low	$0.83
Previous Close	$1.76
Volume	174.88K
Average Volume	1.30M
P/E Ratio	--
52-Week High	$5.55
52-Week Low	$1.03
Dividend Yield	--
Earnings Date	--

Pyxis Oncology, Inc. (PYXS) Stock Price Today

Pyxis Oncology, Inc. (PYXS) is currently trading at $1.86 as of 2026-10-20 14:20:33, up 5.40% ($0.09) from the previous close of $1.76

During today's regular trading session, PYXS has traded between $0.83 and $19.00, with a trading volume of 174.88K shares. The current price is near the lower end of today's range.

Pyxis Oncology, Inc. (PYXS) 7-Day Stock Price Change

Over the past seven days, Pyxis Oncology, Inc. (PYXS) moved from $2.03 to $1.86, representing a decline of 8.62% ($0.17).

The stock traded between $1.66 and $2.08 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.

The average daily volume was 912.50 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

PYXS 52-Week Price Position

Position in Range: 18.3%

52W Low$1.03

52W High$5.55

PYXS is currently trading at $1.86, placing it 18.3% of the way from its 52-week low of $1.03 to its 52-week high of $5.55. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Pyxis Oncology, Inc. (PYXS)?

Pyxis Oncology Inc is a clinical-stage oncology company focused on developing therapies for patients with solid tumors, with an initial emphasis on head and neck squamous cell carcinoma. Its product candidate, micvotabart pelidotin (MICVO, formerly PYX-201), is an investigational antibody-drug conjugate that targets extradomain-B fibronectin (EDB+FN), a component of the tumor extracellular matrix that is expressed in tumors and minimally present in normal tissues. MICVO consists of a fully human monoclonal antibody linked to a microtubule inhibitor payload, designed to bind within the tumor microenvironment and release its payload to kill cancer cells directly, affect nearby cells through a bystander effect, and induce immunogenic cell death, supporting enhanced anti-tumor activity.

Pyxis Oncology, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	56
Exchange	NASDAQ
Company Website	https://www.pyxisoncology.com

How to Buy Pyxis Oncology, Inc. (PYXS) Stock on MEXC

Eligible investors can buy real shares of Pyxis Oncology, Inc. (PYXS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for PYXS and Place Your Order

Open the RealStocks trading page and search for PYXS. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Pyxis Oncology, Inc. (PYXS) stock price today?

Pyxis Oncology, Inc. (PYXS) is currently trading at $ 1.86, up 5.40% ($0.09) from the previous close of $ 1.76. Intraday prices update in real time during regular trading hours.

2.Is PYXS stock going up or down today?

As of 2026-10-20 14:20:33, PYXS is trading at $ 1.86, up 5.40% ($0.09) from its previous close of $ 1.76. The stock has traded between $ 0.83 and $ 19.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is PYXS pre-market price?

As of 2026-10-20 14:20:33, PYXS is trading at $ 1.79 in pre-market trading, up 1.42% ($0.02) from the previous close of $ 1.76. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is PYXS after-hours price?

As of 2026-10-20 14:20:33, PYXS is trading at $ 1.79 in after-hours trading, up 1.87% ($0.03) from the regular-session close of $ 1.76. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is PYXS stock trading now?

PYXS trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does PYXS sit relative to its 52-week high and low?

Over the past 52 weeks, PYXS has traded between a low of $ 1.03 and a high of $ 5.55. At $ 1.86, the stock is positioned 18.3% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Pyxis Oncology, Inc. in?

Pyxis Oncology, Inc. (PYXS) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Pyxis Oncology, Inc.'s market capitalization and where is it listed?

Pyxis Oncology, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 140.13M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is PYXS valued in terms of P/E ratio and EPS?

PYXS trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.06. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Pyxis Oncology, Inc. pay a dividend?

Pyxis Oncology, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.